Oral Challenge without Skin Testing Safely Excludes Clinically Significant Delayed-Onset Penicillin Hypersensitivity
- PMID: 28483317
- DOI: 10.1016/j.jaip.2017.02.023
Oral Challenge without Skin Testing Safely Excludes Clinically Significant Delayed-Onset Penicillin Hypersensitivity
Abstract
Background: Penicillins are the drug family most commonly associated with hypersensitivity reactions. Current guidelines recommend negative skin tests (ST) before re-administering penicillins to patients with previous nonimmediate reactions (NIR).
Objective: The objective of this study was to examine whether ST are necessary before re-administering penicillin to patients with NIR.
Methods: Patients with NIR to penicillins starting longer than 1 hour after last dose administration or starting any time after the first treatment day or patients with vague recollection of their reaction underwent penicillin ST. Disregarding ST results, patients were challenged with the relevant penicillins. One-tenth of the therapeutic dose followed by the full dose was administered at 1-hour interval and patients continued taking the full dose for 5 days.
Results: A total of 710 patients with alleged BL allergy were evaluated. Patients with a history of immediate reaction (52, 7.3%) or cephalosporin allergy (16, 2.2%) were excluded. Of the remaining 642 patients, 62.3% had negative ST, 5.3% positive ST, and 32.4% equivocal ST. A total of 617 (96.1%) patients were challenged. Immediate reaction was observed in 9 patients (1.5%): 1-positive ST, 7-negative ST, and 1-equivocal ST (P = .7). Late reaction to the first-day challenge occurred in 24 patients (4%). An at-home challenge was continued by 491 patients. Complete 5-day and partial challenges were well tolerated by 417 (85%) and 44 patients (8.9%), respectively, disregarding ST results. Thirty patients (6.1%) developed mild reactions to the home challenge regardless of their ST results.
Conclusion: A 5-day oral challenge without preceding ST is safe and sufficient to exclude penicillin allergy after NIR developing during penicillin treatment.
Keywords: Beta-lactams; Drug hypersensitivity; Nonimmediate penicillin allergy; Oral challenge.
Copyright © 2017 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
Comment in
-
Moving Toward Optimizing Testing for Penicillin Allergy.J Allergy Clin Immunol Pract. 2017 May-Jun;5(3):684-685. doi: 10.1016/j.jaip.2017.03.020. J Allergy Clin Immunol Pract. 2017. PMID: 28483319 No abstract available.
Similar articles
-
Positive Skin Test or Specific IgE to Penicillin Does Not Reliably Predict Penicillin Allergy.J Allergy Clin Immunol Pract. 2017 May-Jun;5(3):676-683. doi: 10.1016/j.jaip.2017.03.014. J Allergy Clin Immunol Pract. 2017. PMID: 28483318
-
Diagnosis of penicillin allergy revisited: the value of case history, skin testing, specific IgE and prolonged challenge.Allergy. 2013 Aug;68(8):1057-64. doi: 10.1111/all.12195. Epub 2013 Jul 29. Allergy. 2013. PMID: 23889703
-
Diagnosis of penicillin, amoxicillin, and cephalosporin allergy: reliability of examination assessed by skin testing and oral challenge.J Pediatr. 1998 Jan;132(1):137-43. doi: 10.1016/s0022-3476(98)70499-8. J Pediatr. 1998. PMID: 9470015
-
Update on penicillin allergy delabeling.Curr Opin Pediatr. 2020 Apr;32(2):321-327. doi: 10.1097/MOP.0000000000000879. Curr Opin Pediatr. 2020. PMID: 32068593 Review.
-
Penicillin Allergy Testing Should Be Performed Routinely in Patients with Self-Reported Penicillin Allergy.J Allergy Clin Immunol Pract. 2017 Mar-Apr;5(2):333-334. doi: 10.1016/j.jaip.2016.12.010. J Allergy Clin Immunol Pract. 2017. PMID: 28283158 Review. No abstract available.
Cited by
-
Challenging dogmas: Intravenous versus oral beta-lactam antibiotic provocation tests.World Allergy Organ J. 2024 May 24;17(6):100914. doi: 10.1016/j.waojou.2024.100914. eCollection 2024 Jun. World Allergy Organ J. 2024. PMID: 38855082 Free PMC article.
-
Introduction of a penicillin allergy de-labelling program with direct oral challenge and its effects on utilization of beta-lactam antimicrobials: a multicenter retrospective parallel cohort study.Allergy Asthma Clin Immunol. 2024 Mar 5;20(1):20. doi: 10.1186/s13223-024-00877-9. Allergy Asthma Clin Immunol. 2024. PMID: 38444037 Free PMC article.
-
Approach for delabeling beta-lactam allergy in children.Front Allergy. 2023 Nov 15;4:1298335. doi: 10.3389/falgy.2023.1298335. eCollection 2023. Front Allergy. 2023. PMID: 38033918 Free PMC article. Review.
-
Standardized testing and written communication improve patient understanding of beta-lactam allergy testing outcomes: A multicenter, prospective study.J Allergy Clin Immunol Glob. 2022 Jun 2;1(3):99-105. doi: 10.1016/j.jacig.2022.05.003. eCollection 2022 Aug. J Allergy Clin Immunol Glob. 2022. PMID: 37781263 Free PMC article.
-
The state and consideration for skin test of β-lactam antibiotics in pediatrics.Front Cell Infect Microbiol. 2023 Jun 15;13:1147976. doi: 10.3389/fcimb.2023.1147976. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37396306 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
